A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Locations

Brain Imaging Center (BIC)
University of Colorado Hospital

Principal Investigator
Photograph of Enrique Alvarez

Enrique Alvarez

Study ID

Protocol Number: 20-2036

More information available at ClinicalTrials.gov: NCT04586010

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers